Aline Hébrant
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
-
- Thyroid Cancer Diagnosis and Treatment
- Thyroid Disorders and Treatments
Papers in
-
- Cancer Genomics and Diagnostics 9
- MicroRNA in disease regulation 3
-
- Gene expression and cancer classification 2
- Co-authors
- Carine Maenhaut (14 shared papers)J.E. Dumont (4 shared papers)Wilma C.G. van Staveren (8 shared papers)Vincent Detours (2 shared papers)Leonardo M. R. Ferreira (1 shared paper)Maxime Tarabichi (3 shared papers)David Solís (1 shared paper)Jacques E. Dumont (8 shared papers)
- Journals
- PLoS ONE (3 papers)Experimental Cell Research (2 papers)Oncogene (2 papers)Cancers (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Aline Hébrant
22 papers receiving 891 citations
Peers
Comparison fields: 5 of 98
- Cancer Research 252
- Endocrinology, Diabetes and Metabolism 235
- Oncology 210
- Molecular Biology 423
- Biotechnology 25
Countries citing papers authored by Aline Hébrant
This map shows the geographic impact of Aline Hébrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Hébrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Hébrant more than expected).
Fields of papers citing papers by Aline Hébrant
This network shows the impact of papers produced by Aline Hébrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Hébrant. The network helps show where Aline Hébrant may publish in the future.
Co-authors
The 25 scholars most cited alongside Aline Hébrant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 170 | |
| 2 | 2012 | 130 | |
| 3 | 2012 | 107 | |
| 4 | 2012 | 100 | |
| 5 | 2012 | 59 | |
| 6 | 2010 | 58 | |
| 7 | 2013 | 48 | |
| 8 | 2014 | 39 | |
| 9 | 2010 | 35 | |
| 10 | 2019 | 32 | |
| 11 | 2013 | 29 | |
| 12 | 2018 | 18 | |
| 13 | 2009 | 18 | |
| 14 | 2007 | 15 | |
| 15 | 2014 | 10 | |
| 16 | 2021 | 8 | |
| 17 | 2012 | 7 | |
| 18 | 2015 | 7 | |
| 19 | 2012 | 5 | |
| 20 | 2020 | 4 |
About Aline Hébrant
Aline Hébrant is a scholar working on Cancer Research, Molecular Biology, Oncology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 24 papers that have together received 902 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Thyroid Cancer Diagnosis and Treatment (6 papers), Genetic factors in colorectal cancer (4 papers), Cancer-related Molecular Pathways (3 papers), MicroRNA in disease regulation (3 papers), Gene expression and cancer classification (2 papers), Cancer Cells and Metastasis (2 papers) and Thyroid Disorders and Treatments (2 papers). The work is most often cited by research in Cancer Research (252 citations), Endocrinology, Diabetes and Metabolism (235 citations), Oncology (210 citations), Molecular Biology (423 citations) and Biotechnology (25 citations). Aline Hébrant has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Carine Maenhaut, J.E. Dumont, Wilma C.G. van Staveren, Vincent Detours, Leonardo M. R. Ferreira, Maxime Tarabichi, David Solís, Jacques E. Dumont, Sébastien L. Floor and Manuel Saiselet. Their work appears in journals such as PLoS ONE, Experimental Cell Research, Oncogene, Cancers and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.